×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Special Population Study Challenges
Session Chair(s)
William B. Smith, MD
CEO
Alliance for Multispecialty Research, LLC , United States
Early phase pharmacokinetic studies continue to be challenging. Current issues from regulatory, CRO/Sponsor, and site perspectives will be discussed and suggestions for optimizing protocols and operations will be presented.
Learning Objective : Describe the design challenges of special population studies; Develop practical solutions to special population study obstacles.
Speaker(s)
Critical Challenges in Conducting PK Studies in Patients and Special Populations
Charu Gautam, MD
IQVIA, India
Senior Medical Director
Special Population Studies: Thirty Years Experience Shared
Harry Alcorn, PharmD
Elixia Health, United States
Chief Scientific Officer
Have an account?